Renovaro amends consulting agreement with Interim CFO Simon Tarsh; $25k/month plus options

Lunai Bioworks Inc.

Simon Tarsh continues as Interim CFO under amended agreement; monthly fee $25,000.
Tarsh received $29,063 bonus on Oct 31 and will receive another $29,063 on Nov 30.
Granted 58,500 stock options under 2023 Equity Incentive Plan; vest if new CFO hired before termination.
Agreement term is 3 months, renewable monthly; either party may terminate on 30 days notice.
Tarsh eligible for target bonus up to 30% of total consideration if milestones achieved (timely SEC filings and new CFO).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.